Characterization of tomographic findings in patients with COVID 19 and suspected pulmonary fibrosis

Rolando Dornes-Ramón; Yunelkys Martínez Castro; Aymé Alberna Cardoso; Yordany Vázquez Mora; Damavys López Baró; Yander Luis Izaguirre Campillo

2022, Number 4

<< Back Next >>

Rev cubana med 2022; 61 (4)

Characterization of tomographic findings in patients with COVID 19 and suspected pulmonary fibrosis

Dornes-Ramón R, Martínez CY, Alberna CA, Vázquez MY, López BD, Izaguirre CYL

Full text

How to cite this article

Language: Spanish
References: 30
Page: 1-13
PDF size: 389.18 Kb.

ABSTRACT

Introduction: The tomographic evaluation of the thorax allows us to know the complications in patients with COVID-19, pulmonary fibrosis being one of the most feared, due to its impact on lung function.
Objective: To characterize the tomographic findings in patients with COVID-19 and suspected pulmonary fibrosis.
Methods: A retrospective descriptive observational study was carried out at the Cuban Hospital in Qatar, between April 2020 and April 2021, the universe consisted of 129 patients with COVID 19, the sample was made up of 85 patients with radiographic suspicion of Pulmonary Fibrosis. The information was obtained from the medical records. Bioethical principles were taken into account.
Results: The male sex prevailed, the age group of 45-59 years. The ground glass pattern was the most frequent in 60% of the cases. There were tomographic signs of Pulmonary Fibrosis in 58.62%, with diagnosis in advanced phase, moderate extension, bilateral and diffuse location. Multilobar involvement was the most frequent in patients with evident fibrosis and in those with doubtful pulmonary fibrosis.
Conclusions: Male patients aged between 45-59 years predominated. The ground glass pattern was the most frequent. In more than half of the patients, signs of pulmonary fibrosis were evidenced in the advanced phase of COVID -19, with moderate extension. Bilateral and diffuse localization predominated. Multilobar involvement was the most frequent in patients with evident fibrosis and in those with doubtful pulmonary fibrosis. The contribution of this research lies in the fact that with the characterization of the tomographic findings in patients with COVID 19, future complications are prevented.

REFERENCES

Yang W, Sirajuddin A, Zhang X, Liu G, Teng Z, Zhao S, Lu M. El papel de las imágenes en la neumonía por coronavirus novedoso de 2019 (COVID-19). Eur Radiol. 2020;30(9):4874-82. DOI: https://doi.org/10.1007/s00330-020-06827-41.
Díaz Santos G, Matiz CE, Pinzón B. Presentación de la enfermedad pulmonar intersticial durante la pandemia de COVID-19. Rev. Colomb Neumol. 2021 [acceso: 30/09/2021];32(1):78-86. Disponible en: Disponible en: https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/514 2.
Dueñas Castel C, Ortiz Ruiz G, Garay Fernández M. El cuidado crítico en el paciente con COVID-19. Rev. Colomb Neumol. 2021 [acceso: 30/09/2021];32(1):115-23. Disponible en: Disponible en: https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/518 3.
Baldi BG, Tanni SE. Fibrosis pulmonar y seguimiento de supervivientes de COVID-19: una necesidad urgente de aclaración. J Bras Pneumol. J2021;47(4):e20210213. DOI: https://doi:10.36416/1806-3756/e202102134.
Kiekens C, Boldrini P, Andreoli A, Avesani R, Gamna F, Grandi M, et al. Rehabilitación y manejo respiratorio en la fase aguda y posaguda temprana. "Informe instantáneo de campo" sobre respuestas de rehabilitación a la emergencia COVID-19. Eur J Phys Rehabil Med. 2020;56 (3):323-26. DOI: https://doi.org/10.23736/S1973-9087.20.06305-45.
Chérrez-Ojeda I, Gochicoa-Rangel L, Salles-Rojas A, Mautong H. Seguimiento de los pacientes después de neumonía por COVID-19. Rev. Alerg Mex. 2020;67(4):350-69. DOI: https://doi:10.29262/ram.v67i4.8476. . PMID: 33631903.
Reyes CF. Definición, patogenia y factores de riesgo de la fibrosis pulmonar idiopática. Rev. Chilen Ferm Respir. 2019;35(4):261-63. DOI: http://dx.doi.org/10.4067/S0717-734820190004002617.
Parra Gordo ML, Weiland GB, García MG, Choperena GA. Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications. Radiol Engl Ed. 2021;63(1):74-88. English, Spanish. DOI: https://doi:10.1016/j.rx.2020.11.002.Epub2020Nov258.
Torres González JV, Botero JD, Celis Preciado CA, Fernández MJ, Villaquirán C, García OM, et al. Fibrosis pulmonar en infección por SARS-CoV-2: ¿qué sabemos hasta hora? ¿Qué podemos esperar? Univ Med Col. 2020;61(4). DOI: https://doi.org/10.11144/Javeriana.umed61-4.fibr9.
Muñoz Nuñez CF. Valoración radiológica de las secuelas pulmonares en la Covid-19 ANALES RANM. Real Academia Nacional de Medicina de España; An RANM 2020;137(03):298-304. DOI: https://doi:10.32440/ar.2020.137.03.doc0110.
Wong HYF, Lam HYS, Fong AH-T, Leung ST, Chin TW-Y, Lo CSY, et al. Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients. Radiol 2020; 201160. DOI: https://pubs.rsna.org/doi/10.1148/radiol.202020116011.
Soriano Aguadero I, Ezponda Casajús A, Mendoza Ferradas F, Igual Rouilleault A, Paternain Nuin A, Pueyo Villoslada J, et al. Hallazgos en la tomografía computarizada de tórax en las fases evolutivas de la infección por SARS-CoV-2. Rev. Radiol. 2021;63(3):218-27. Spanish. DOI: https://doi: 10.1016/j.rx.2021.02.00412. . Epub 2021 Feb 27. PMCID: PMC7914007.
Carlos Díaz PJ, Palavecino BT, Gonzalo Pereira R. Tomografía computada de alta resolución en el diagnóstico de la fibrosis pulmonar idiopática. Rev. chil enferm Respir. 2019;35(4):268-74. DOI: http://dx.doi.org/10.4067/S07177348201900040026813.
. Asociación Médica Mundial. Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos. Ratificada en la 64ª Asamblea General, Fortaleza, Brasil, octubre 2013. Helsinki: 18ª Asamblea Mundial; 1964 [acceso: 26/01/2019]. Disponible en: Disponible en: http://www.anmat.gov.ar/comunicados/HELSINSKI_2013.pdf 14.
George PM, Wells AU, Gisli Jenkins R. Pulmonary fibrosis, and COVID-19: the potential role for antifibrotic therapy. The Lancet Respirat Med. 2020;8(8):807-15. ISSN 2213-2600. DOI: https://doi.org/10.1016/S2213-2600(20)3022515.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199- 1207. DOI: https://doi:10.1056/NEJMoa200131616.
British Thoracic Society Advice for Managing Interstitial Lung Disease Patients during COVID-19 pandemic. 2020 [acceso: 25/10/2021] Disponible en: Disponible en: https://www.britthoracic.org.uk/media/455101/bts-management-advice-for-ild-patients-v10-23- march-2020.pdf 17.
. Tabernero Huguet E, Urrutia Gajarte A, Ruiz Iturriaga LA, Serrano Fernández L, Marina Malanda N, Iriberri Pascual M, et al. Pulmonary Function in Early Follow-up of patients with COVID-19 Pneumonia. Arch Bronconeumol. 2021 [acceso: 25/10/2021];57:75-76. Spanish. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S0300289620302520 18.
Ashtari S, Vahedian-Azimi A, Shojaee S, Pourhoseingholi MA, Jafari R, Bashar FR, et al. Computed tomographic features of coronavirus disease-2019 (COVID-19) pneumonia in three groups of Iranian patients: A single center study. Radiol. 2021;63(4):314-23. DOI: https://doi: 10.1016/j.rx.2021.03.00219. . Epub 2021 Mar 14. PMCID: PMC7955942.
Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies. Pulm Med. 2020;2020:6175964. DOI: https://doi: 10.1155/2020/617596420. . PMID: 32850151; PMCID: PMC7439160.
Hernando JEC. Criterios de seguimiento de los pacientes con afectación respiratoria grave por SARS-CoV-2. FMC. 2021;28(5):266-72. DOI: https://doi: 10.1016/j.fmc.2020.10.00721. . Epub 2021 May 12. PMID: 33994776; PMCID: PMC8114519.
Huang C, Wang Y, Li x, Ren L, Zhao J, Hu J. Clinical features of patient infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-522.
Zhou Z, Guo D, Li C, Fang Z, Chen L, Yang R, et al. Coronavirus disease 2019: initial chest CT findings. Eur Radiol. 2020;30:4398-406. DOI: https://doi.org/10.1007/s00330-020-06816-723.
Wang YC, Luo H, Liu S, Huang S, Zhou Z, Yu Q, et al. Dynamic evolution of COVID-19 on chest computed tomography: experience from Jiangsu Province of China. Eur Radiol. 2020;30:6194-203.DOI: http://dx.doi.org/10.1007/s00330-020-06976-624.
Tiralongo F, Palermo M, Distefano G, Vancheri A, Sambataro G, Torrisi SE, et al. Cryptogenic Organizing Pneumonia: Evolution of Morphological Patterns Assessed by HRCT. Diagnostics. 2020;10(5):262. DOI: https://doi.org/10.3390/diagnostics1005026225.
Hani C, Trieu NH, Saab I, Dangeard S, Bennani S, Chassagnon G, et al. COVID-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imaging. 2020;101(5):263-68. DOI: https://doi: 10.1016/j.diii.2020.03.01426. . Epub 2020 Apr 3. PMID: 32291197; PMCID: PMC7129663.
Jalaber C, Lapotre T, Morcet-Delattre T, Ribet F, Jouneau S, Lederlin M. Chest CT in COVID-19 pneumonia: a review of current knowledge. Diagn Interv Imaging. 2020;101(7-8):431-37. DOI: https://doi:10.1016/j.diii.2020.06.00127. .Epub 2020 Jun 11. PMID: 32571748; PMCID: PMC7287482.
. Casan Clarà P, Martínez González C. Pos- COVID-19 pneumology. Arch Bronconeumol. 2020 [acceso: 04/02/2021];56(2):3-4. Disponible en: Disponible en: https://www. archbronconeumol.org/en-linkresolver-la-neumologiapos-covid-19-S0300289620301630 28.
Carloni A, Poletti V, Fermo L, Bellomo N, Chilosi M. Heterogeneous distribution of mechanical stress in human lung: a mathematical approach to evaluate abnormal remodeling in IPF. J Theor Biol. 2013;332:136-40. DOI: https://doi:10.1016/j.jtbi.2013.04.03829. . Epub 2013 May 9. PMID: 23665208.
Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms?. Lancet Respir Med. 2020;8(8):750-52. DOI: https://doi:10.1016/S2213-2600(20)30222-830. .Epub 2020May15.PMID: 32422177; PMCID: PMC7228737.